Penile cancer is an infrequent neoplasm, with one or two cases per year per hundred thousand inhabitants, but it has a high impact on the patient’s health, both for its aggressiveness and for the aftereffects caused by its treatment.
For these reasons, it is recommended that these cases be assessed at experienced centres that are a reference in the field.
They present in a variety of ways, and can be difficult to diagnose in the early stages. They are usually diagnosed following the observation of excrescent lesions on the penis, usually on the glans and foreskin.
The correct diagnosis and treatment of the possible involvement of the lymph nodes draining the cancer at the inguinal level is of crucial importance.
The urology service of the IVO uses the sentinel node technique for diagnosing the affected nodes with minimal surgical aggression, as well as the innovative technique of videoendoscopic inguinal surgery, which reduces the complications and aftereffects related to conventional inguinal surgery.
It accounts for 1% of male cancers in The West.
In early stages, they can either be treated with topical treatments or conservative techniques, using laser or photodynamic therapy. More advanced situations will require conventional surgical treatment with greater or lesser aftereffects on the damaged organ.
In this sense, both the Dermatology and Urology services have the experience and technology necessary to carry out a successful local treatment with the least possible level of amputation. Mohs micrographic surgery can be performed to ensure disease-free surgical margins and/or reconstructive techniques on the penis that achieve better aesthetic and functional results.
The Urological Tumour Committee is made up of a multidisciplinary team of expert professionals.
The Urology Service offers alternatives for the prevention, diagnosis and treatment of urological tumours
The Service's team of professionals accompanies cancer patients throughout the whole disease process.
A clinical trial is a research study carried out on people with the aim of learning more about how the body reacts to certain treatments. These trials generally seek to find drugs that are more effective than the current best therapeutic option for patients, or that have similar efficacy but a better toxicity profile.
Bearing in mind that almost all currently available treatments are the result of clinical research, the importance of clinical trials is obvious.
The IVO has a clinical trials unit for all types of tumours and participates in phase 1-3 studies as well as other types of studies.
Whether you receive the news of an initial diagnosis of cancer or a relapse, coping with cancer can be emotionally overwhelming. Each person has their own way of coping with a penile cancer diagnosis, but there are some recommendations that can help you through this process:
© 2022 IVO Fundación Instituto Valenciano de Oncología